Overview

High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

Status:
Unknown status
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well pemetrexed disodium works in treating patients with Lung Adenocarcinoma With Brain Metastases
Phase:
Phase 2
Details
Lead Sponsor:
Rongjie Tao
Collaborator:
National Natural Science Foundation of China
Treatments:
Pemetrexed